Qiong B. Pan

Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

PTK2/FAK inhibition triggers TMED9-mediated protective autophagy in pancreatic cancer cell via enhancing ERGIC-ERES contact.

PTK2/FAK inhibition triggers TMED9-mediated protective autophagy in pancreatic cancer cell via enhancing ERGIC-ERES contact.

Journal: Autophagy

Published: May 18, 2026

Precise clinical classification of metabolic associated fatty liver disease

Precise clinical classification of metabolic associated fatty liver disease

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: April 26, 2026

Development and validation of clinical phenotypes in sepsis-associated liver injury using multi-algorithm consensus classification: a retrospective cohort study.

Development and validation of clinical phenotypes in sepsis-associated liver injury using multi-algorithm consensus classification: a retrospective cohort study.

Journal: BMC infectious diseases

Published: November 06, 2025

PTP4A3 dephosphorylates EGFR to promote metastasis and enhance sensitivity to lapatinib in hepatocellular carcinoma.

PTP4A3 dephosphorylates EGFR to promote metastasis and enhance sensitivity to lapatinib in hepatocellular carcinoma.

Journal: Oncogene

Published: September 28, 2025

Liver-pancreas communication in disease and drug development.

Liver-pancreas communication in disease and drug development.

Journal: Acta pharmaceutica Sinica. B

Published: August 07, 2025

Hepatocyte SLCO4C1 is a cAMP uptake transporter for inhibiting lipogenesis and a therapeutic target for MASLD.

Hepatocyte SLCO4C1 is a cAMP uptake transporter for inhibiting lipogenesis and a therapeutic target for MASLD.

Journal: Nature communications

Published: June 20, 2025

The SEMA7AN559Y mutation facilitates the development of metabolic dysfunction-associated steatotic liver disease by inducing ROS/NLRP3-mediated hepatic cell pyroptosis.

The SEMA7AN559Y mutation facilitates the development of metabolic dysfunction-associated steatotic liver disease by inducing ROS/NLRP3-mediated hepatic cell pyroptosis.

Journal: Metabolism: clinical and experimental

Published: May 30, 2025

The role of bile acid dynamics in inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease.

The role of bile acid dynamics in inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease.

Journal: Liver research (Beijing, China)

Published: May 09, 2025

Disruption of Hepatic Sinusoidal Homeostasis Leads to Hepatopulmonary Syndrome.

Disruption of Hepatic Sinusoidal Homeostasis Leads to Hepatopulmonary Syndrome.

Journal: Journal of cellular and molecular medicine

Published: February 06, 2025

Conjugated bile acid-driven CD14+CD16+ monocyte infiltration promotes cholestatic liver injury by enhancing hepatocyte necroptosis.

Conjugated bile acid-driven CD14+CD16+ monocyte infiltration promotes cholestatic liver injury by enhancing hepatocyte necroptosis.

Journal: JHEP reports : innovation in hepatology

Published: December 01, 2024

Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population.

Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population.

Journal: Science translational medicine

Published: November 06, 2024

Spatially resolved multi-omics of human metabolic dysfunction-associated steatotic liver disease.

Spatially resolved multi-omics of human metabolic dysfunction-associated steatotic liver disease.

Journal: Nature genetics

Published: July 27, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026